The Recall Desk

Hazard

Tablet Breakage recalls

5 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
5
Critical
0
Severe
0
Most recent
2022-08-17

Of the 5 tablet breakage recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all tablet breakage recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

1–5 of 5

  • ModerateFDA (Drugs)·D-1305-2022·2022-08-17

    Prescription Drug Recall: Telmisartan-Hydrochlorothiazide Tablets Due to Defective Packaging

    Glenmark Pharmaceuticals recalls 72,288 units of Telmisartan-Hydrochlorothiazide 80/25 mg tablets nationwide due to defective blister packaging that is difficult to open and causes tablets to break.

    Product
    TELMISARTAN AND HYDROCHLOROTHIAZIDE — TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1306-2022·2022-08-17

    Glenmark Pharmaceuticals Recalls Telmisartan/Hydrochlorothiazide Due to Defective Blister Packs

    Glenmark Pharmaceuticals Inc., USA is recalling specific lots of Telmisartan and Hydrochlorothiazide tablets due to complaints of defective blister packs that are difficult to open and cause tablets to break during removal.

    Product
    TELMISARTAN AND HYDROCHLOROTHIAZIDE — TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1018-2018·2018-08-08

    Vensun Pharmaceuticals Recalls Potassium Citrate Tablets Due to Breakage

    Vensun Pharmaceuticals is recalling 3,683 bottles of Potassium Citrate Extended-Release Tablets because they failed specifications due to tablet breakage.

    Product
    POTASSIUM CITRATE — POTASSIUM CITRATE (POTASSIUM CITRATE)
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-1017-2018·2018-08-08

    Vensun Recalls Potassium Citrate Tablets Due to Tablet Breakage

    Vensun Pharmaceuticals is recalling 11,652 bottles of Potassium Citrate Extended-Release Tablets because they failed specifications due to tablet breakage.

    Product
    POTASSIUM CITRATE — POTASSIUM CITRATE (POTASSIUM CITRATE)
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-205-2013·2013-03-27

    Watson Recalls Zarah Oral Contraceptive Tablets Due to Breakage

    Watson Laboratories is recalling Zarah oral contraceptive tablets because they may break while being pushed through the blister pack.

    Product
    ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28
    Category
    Drug
    Distribution
    Distributed nationwide
Tablet Breakage recalls · The Recall Desk